Hillan Kenneth J. 4
4 · 23andMe Holding Co. · Filed Feb 11, 2022
Insider Transaction Report
Form 4
Hillan Kenneth
Head of Therapeutics
Transactions
- Award
Class A Common Stock
2022-02-09+214,091→ 214,091 total - Award
Stock Option (Right to Buy)
2022-02-09+471,413→ 471,413 totalExercise: $5.00Exp: 2032-02-09→ Class A Common Stock (471,413 underlying)
Footnotes (2)
- [F1]Grant of restricted stock units (the "RSUs") under the 23andMe Holding Co's (the "Company") 2021 Incentive Equity Plan (the "Plan"). The RSUs vest equally in 1/16 quarterly installments commencing on May 20, 2022. The vesting of the RSUs is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations. Each RSU represents the contingent right to receive one share of Class A common stock of the Company.
- [F2]Grant of stock options under the Plan. The stock options vest equally in 1/48 monthly installments commencing on March 9, 2022. The vesting of the options is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations.